title: Should the extreme drug resistance assay fade into oblivion? Commentary on Karam, A.K., Chiang, J.W., Fung, E., Nossov, V. and Karlan, B.Y. Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer. Gynecol Oncol. 2009;114:246-252.
authors.forename: Jens
authors.initials: J
authors.lastname: Einenkel
authors.forename: Patricia
authors.initials: P
authors.lastname: Wuttke
authors.forename: Katharina
authors.initials: K
authors.lastname: Horn
mesh_terms: D019008:Drug Resistance, Neoplasm; D004354:Drug Screening Assays, Antitumor; D004847:Epithelial Cells / Q000473:pathology; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D015996:Survival Rate